METTL5 Promotes Tumor Progression in Oral Squamous Cell Carcinoma by Activating the Myc Pathway
Journal of Oral Pathology & Medicine · 2025-02 · 54 (2) · 91-99
DOI: 10.1111/jop.13601 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, online erschienen am 27.01.2025. Verfasst von Rong Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Taizhou Polytechnic College, Taizhou, Jiangsu Province, China. Hauptthemen laut MEDLINE: Mouth Neoplasms, Methyltransferases, Proto-Oncogene Proteins c-myc, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: The Science and Technology Development Fund of Nanjing Medical University, The academy level scientific research project of Taizhou Polytechnic College.
Abstract (Originalsprache)
Background
It has been observed that methyltransferases‐like 5 (METTL5) is a key mediator underlying tumorigenesis in humans. This study aimed to investigate the biological function, expression pattern, and clinical significance of METTL5 in oral squamous cell carcinoma (OSCC).
Methods
Bioinformatics interrogations and immunohistochemical staining were utilized for determining the expression and localization of METTL5 in OSCC, and revealing the relationship between the expression of METTL5 and prognosis. Cell phenotype experiments and xenograft models were used to detect the impact of METTL5 silencing on OSCC. Gene Set Enrichment Analysis, Spearman correlation, and c‐Myc overexpression plasmid was utilized for exploring the regulatory effects of METTL5 on the Myc pathway.
Results
METTL5 was overexpressed in OSCC and correlated with reduced survival. Cell proliferation, migration, and invasion were significantly inhibited by METTL5 knockdown in vitro, and tumor growth was impaired in vivo. Moreover, METTL5 was capable of activating the Myc pathway. The influences of knockdown of METTL5 on Cal27 cell biological behaviors were reversed by overexpression of c‐Myc.
Conclusions
Our data suggested that METTL5 may act as a putative oncogene and prognostic biomarker in OSCC. The Myc pathway appears to be involved in cell proliferation, migration, invasion, and apoptosis in OSCC mediated by METTL5.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Taizhou Polytechnic College, Taizhou, Jiangsu Province, China.
- The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian, Jiangsu Province, China.
Förderung
- The Science and Technology Development Fund of Nanjing Medical University
- The academy level scientific research project of Taizhou Polytechnic College
Zitieren
APA
Huang, R., Feng, X., Zhou, T., Lu, J., Wang, Y., Zhang, S., & Zhang, W. (2025). METTL5 Promotes Tumor Progression in Oral Squamous Cell Carcinoma by Activating the Myc Pathway. Journal of Oral Pathology & Medicine, 54(2), 91-99. https://doi.org/10.1111/jop.13601
Vancouver
Huang R, Feng X, Zhou T, Lu J, Wang Y, Zhang S, et al. METTL5 Promotes Tumor Progression in Oral Squamous Cell Carcinoma by Activating the Myc Pathway. Journal of Oral Pathology & Medicine. 2025;54(2):91-99. doi:10.1111/jop.13601
BibTeX
@article{Huang2025,
author = {Huang, Rong and Feng, Xingyu and Zhou, Tao and Lu, Jiajing and Wang, Ying and Zhang, Shuangyue and Zhang, Wei},
title = {METTL5 Promotes Tumor Progression in Oral Squamous Cell Carcinoma by Activating the Myc Pathway},
journal = {Journal of Oral Pathology & Medicine},
year = {2025},
volume = {54},
number = {2},
pages = {91--99},
doi = {10.1111/jop.13601}
}
EUVIMED